CTRI/2025/07/091384已完成不适用
A clinical study to evaluate the Efficacy of Holo Liver Detox in the management of Liver disorders
Zeroharm Sciences Private Limited1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年8月6日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- 1. Assessment criteria based on scoring (0-4) Yakritvriddhi (Enlargement of Liver), Avipaka (Indigestion), Angamarda (Bodyache), Vaman (Vomiting), Anaha (Distension), Dourbalya (Generalized Weakness), Udarshool (Abdominal Pain)
研究概览
简要总结
The eligible patients of fatty liver will be treated with Holo Liver detox from Zeroharm Sciences Private Limited an ayurvedic medicine for a duration of three months. Two follow ups will be carried out at the interval of 1 month. Before and After the treatment, laboratory investigations will be carried out to find out the improvements of the patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Subjects who are diagnosed with fatty liver
- •Subjects having complaints of indigestion, pain abdomen, anorexia, fatigue, nausea and fulfilling the criteria of diagnosis 3.Subjects not suffering from any significant illness
- •Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.
排除标准
- •Pregnant or Lactating females Subjects with any cardiac pathology.
结局指标
主要结局
1. Assessment criteria based on scoring (0-4) Yakritvriddhi (Enlargement of Liver), Avipaka (Indigestion), Angamarda (Bodyache), Vaman (Vomiting), Anaha (Distension), Dourbalya (Generalized Weakness), Udarshool (Abdominal Pain)
时间窗: 12 weeks
Aruchi (Loss of Appetite), Mandagni (Weak Digestive System)
时间窗: 12 weeks
次要结局
- Investigations(1. Ultrasound of the Gallbladder and Abdomen (USGW/A))
研究者
DrTarali Baruah
Government Ayurvedic College and Hospital, Jalukbari, Guwahati
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
4 期
Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver DiseaseNCT07274644The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School36
尚未招募
不适用
Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3NCT07353333Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6
已完成
不适用
Helping You Burn Fat Naturally Results from a Human Trial of Zeroharm fat burner TabletsCTRI/2025/08/092541Zeroharm Science Private Limited50
招募中
不适用
Development of a Quantifiable Ultrasound Biomarker for Hepatic SteatosisNCT07270601ContextVision AB110
招募中
1 期
Immune Tolerance Induction After Liver TransplantationNCT07269041University of California, Los Angeles12